Pancreatic cancer is one of the most deadly cancers, ranking amongst the top leading cause
of cancer related deaths in developed countries. Features such as dense stroma …

Background It is well acknowledged that cancer-related pathways play pivotal roles in the
progression of pancreatic cancer (PC). Employing Integrated analysis, we aim to identify the …

Gastric cancer is a heterogeneous tumor that underlying molecular mechanisms are largely
unclear. This study aimed to elucidate the expression level of HGF-c-MET in gastric cancer …

Background Pancreatic cancer is one of most aggressive malignancies with a dismal
prognosis. Activation of PI3K/AKT signaling is instrumental in pancreatic cancer …

Background: Cancer is the abnormal growth of cells in the body due to an imbalance in the
normal apoptotic pathways. The abnormality in the cancer cells makes them malignant …

Simple Summary Pancreatic cancer is predicted to be the second-highest cause of cancer
mortality in the US by 2040. It is driven by various mutations including KRAS, TP53, SMAD4 …

We have reviewed the literature for circular RNAs (circRNAs) with efficacy in preclinical
pancreatic-cancer related in vivo models. The identified circRNAs target chemoresistance …

RON (recepteur d'origine nantais) and MET (hepatocyte growth factor receptor) are tyrosine
kinase receptors. Various cancers have aberrant RON and MET expression and activation …

Adenocarcinoma of the pancreas (PAAD) is one of the deadliest malignant tumors, and
messenger ribonucleic acid vaccines, which constitute the latest generation of vaccine …

Background Pancreatic adenocarcinoma (PAAD) is a highly lethal and aggressive tumor
with poor prognoses. The predictive capability of immune-related genes (IRGs) in PAAD has …